| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print September 26, 2002
Am J Physiol Heart Circ Physiol, 10.1152/ajpheart.01118.2001
Submitted on December 20, 2001
Accepted on September 24, 2002
1 Department of Medicine, Division of Pulmonary and Critical Care, Milwaukee, WI, USA
2 Institut fur Kardiovaskulare Physiologie, Klinikum der Johann Wolfgang Goethe-Universtitat, Milwaukee, Germany
3 Department of Medicine, Division of Pulmonary and Critical Care, Milwaukee, WI, USA; Department of Physiology, Cardiovascular Center, Medical College of Wisconsin, Frankfurt, WI, USA
4 Department of Physiology, Cardiovascular Center, Medical College of Wisconsin, Frankfurt, WI, USA
* To whom correspondence should be addressed. E-mail: medhoram{at}mcw.edu.
Angiogenesis is one of the most recent physiological functions attributed to products of cytochrome P450 (CYP450) enymes. To test this at a molecular level in human cells we used a cloned cDNA for the human endothelial enzyme CYP2C9 to study growth as well as differentiation of human microvascular endothelial cells from the lung (HMVEC-L). Using adenoviral vectors over-expressing mRNA for CYP2C9, we show that presence of CYP2C9 doubles thymidine incorporation and stimulates proliferation of primary cultures of endothelial cells as compared to Ad5-GFP (control) in 24 hours. In addition there is a significant increase of tube formation in matrigel after infection of HMVEC-L with Ad5-2C9 than with Ad5-GFP. More interestingly Ad5-2C9 expressing the antisense product of CYP2C9 (2C9AS) inhibited tube formation as compared to both Ad5-GFP as well as the Ad5-2C9 constructs. Finally we tested the most abundant arachidonic acid metabolite of CYP2C9, 14,15-EET, which induced angiogenesis in vivo, when embedded in matrigel plugs and implanted in adult rats. These data support an important role for CYP2C9 in promoting angiogenesis.
This article has been cited by other articles:
|
|
 |
|
  A. Dhanasekaran, S. Bodiga, S. Gruenloh, Y. Gao, L. Dunn, J. R. Falck, J. N. Buonaccorsi, M. Medhora, and E. R. Jacobs 20-HETE increases survival and decreases apoptosis in pulmonary arteries and pulmonary artery endothelial cells Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H777 - H786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. Webler, U. R. Michaelis, R. Popp, E. Barbosa-Sicard, A. Murugan, J. R. Falck, B. Fisslthaler, and I. Fleming Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1292 - C1301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Medhora, Y. Chen, S. Gruenloh, D. Harland, S. Bodiga, J. Zielonka, D. Gebremedhin, Y. Gao, J. R. Falck, S. Anjaiah, et al. 20-HETE increases superoxide production and activates NAPDH oxidase in pulmonary artery endothelial cells Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L902 - L911. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Yan, S. Chen, B. You, and J. Sun Activation of sphingosine kinase-1 mediates induction of endothelial cell proliferation and angiogenesis by epoxyeicosatrienoic acids Cardiovasc Res, May 1, 2008; 78(2): 308 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Medhora, A. Dhanasekaran, P. F. Pratt Jr., C. R. Cook, L. K. Dunn, S. K. Gruenloh, and E. R. Jacobs Role of JNK in network formation of human lung microvascular endothelial cells Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L676 - L685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Morin, M. Sirois, V. Echave, M. M. Gomes, and E. Rousseau EET Displays Anti-Inflammatory Effects in TNF-{alpha} Stimulated Human Bronchi: Putative Role of CPI-17 Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 192 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Srivastava, V. Kundumani-Sridharan, B. Zhang, A. K. Bajpai, and G. N. Rao 15(S)-Hydroxyeicosatetraenoic Acid-Induced Angiogenesis Requires STAT3-Dependent Expression of VEGF Cancer Res., May 1, 2007; 67(9): 4328 - 4336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Morin, M. Sirois, V. Echave, M. M. Gomes, and E. Rousseau Epoxyeicosatrienoic Acid Relaxing Effects Involve Ca2+-Activated K+ Channel Activation and CPI-17 Dephosphorylation in Human Bronchi Am. J. Respir. Cell Mol. Biol., May 1, 2007; 36(5): 633 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Spector and A. W. Norris Action of epoxyeicosatrienoic acids on cellular function Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dhanasekaran, R. Al-Saghir, B. Lopez, D. Zhu, D. D. Gutterman, E. R. Jacobs, and M. Medhora Protective effects of epoxyeicosatrienoic acids on human endothelial cells from the pulmonary and coronary vasculature Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H517 - H531. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. C. Petersen, D. H. Munzenmaier, and A. S. Greene Angiotensin II infusion restores stimulated angiogenesis in the skeletal muscle of rats on a high-salt diet Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H114 - H120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Fleming and R. Busse Endothelium-Derived Epoxyeicosatrienoic Acids and Vascular Function Hypertension, April 1, 2006; 47(4): 629 - 633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. Imig Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases Am J Physiol Renal Physiol, September 1, 2005; 289(3): F496 - F503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Zhang, H. Cao, and G. N. Rao 15(S)-Hydroxyeicosatetraenoic Acid Induces Angiogenesis via Activation of PI3K-Akt-mTOR-S6K1 Signaling Cancer Res., August 15, 2005; 65(16): 7283 - 7291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Pozzi, I. Macias-Perez, T. Abair, S. Wei, Y. Su, R. Zent, J. R. Falck, and J. H. Capdevila Characterization of 5,6- and 8,9-Epoxyeicosatrienoic Acids (5,6- and 8,9-EET) as Potent in Vivo Angiogenic Lipids J. Biol. Chem., July 22, 2005; 280(29): 27138 - 27146. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
